Physician
Retina-Vitreous Surgeons of Central New York, PC
Retina-Vitreous Surgeons of Central New York, PC was paid $3.29M by Medicaid between Jan 2018 and Nov 2024, across 11 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 72% of everything it billed.
33Billing provider infoRETINA-VITREOUS SURGEONS OF CENTRAL NEW YORK, PC
LIVERPOOL, NY 13088
LIVERPOOL, NY 13088
33aNPI1124012737assigned 09/09/2005
33bProvider typeRetina Specialist (Ophthalmology) Physician
28Total paid$3.29M
24GClaims20,060
24DCodes billed11
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Retina Specialist (Ophthalmology) Physician providers in New York
Rank by total paid#1 of 60
Median peer was paid$52K
This provider vs. median64×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 433 | $18K | |
| 2019 | 1,175 | $47K | |
| 2020 | 1,932 | $89K | |
| 2021 | 3,727 | $543K | |
| 2022 | 4,563 | $1.01M | |
| 2023 | 5,407 | $1.27M | |
| 2024incomplete | 2,823 | $318K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 72% | 1,456 | 1,271 | $2.38M |
| 67028 | Intravitreal injection of a pharmacologic agent | 12% | 4,014 | 3,625 | $404K |
| 92134 | 12% | 12,855 | 11,503 | $404K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.4% | 444 | 444 | $46K |
| 92250 | <1% | 1,019 | 980 | $31K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 72 | 72 | $9K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 80 | 78 | $6K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 64 | 61 | $5K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 31 | 26 | $2K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 12 | 12 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 13 | 13 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, ANNE (BUSINESS SERVICES COORDINATOR)
| Provider | Location | Paid |
|---|---|---|
| Ohio State University | Columbus, OH | $2.76M |
| Osu Neuro-Psychiatric Physician | Columbus, OH | $1.27M |
| Ohio State University | Columbus, OH | $1.20M |
| Osu Health System Anesthesia | Columbus, OH | $1.20M |
| Ohio State University | Columbus, OH | $28K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.